- Home
- NMRK vs PBH Comparison
NMRK vs PBH Comparison
Compare NMRK & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRK | PBH |
|---|---|---|
| Founded | 1929 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 2017 | 2005 |
Fundamental Metrics
Financial Performance| Metric | NMRK | PBH |
|---|---|---|
| Price | $17.31 | $66.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $19.60 | ★ $86.40 |
| AVG Volume (30 Days) | ★ 776.2K | 337.3K |
| Earning Date | 02-25-2026 | 02-05-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ 94.50 | N/A |
| EPS | 0.59 | ★ 4.04 |
| Revenue | ★ $3,160,782,000.00 | $1,110,479,000.00 |
| Revenue This Year | $21.82 | N/A |
| Revenue Next Year | $9.86 | $2.50 |
| P/E Ratio | $29.01 | ★ $16.28 |
| Revenue Growth | ★ 20.95 | N/A |
| 52 Week Low | $9.65 | $57.25 |
| 52 Week High | $19.84 | $90.04 |
Technical Indicators
Market Signals| Indicator | NMRK | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 49.45 | 59.36 |
| Support Level | $16.86 | $63.97 |
| Resistance Level | $18.25 | $68.28 |
| Average True Range (ATR) | 0.63 | 1.72 |
| MACD | -0.01 | 0.14 |
| Stochastic Oscillator | 48.65 | 61.29 |
Price Performance
Historical ComparisonAbout NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.